| Densie Lowell, MASTERS | |
|
1471 Elmwood Ave, Cranston, RI 02910-3849 | |
| (401) 724-8400 | |
| (401) 722-5280 |
| Full Name | Densie Lowell |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 1471 Elmwood Ave, Cranston, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295128635 | NPI | - | NPPES |
| GH57134 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Densie Lowell, MASTERS 1471 Elmwood Ave, Cranston, RI 02910-3849 Ph: (401) 724-8400 | Densie Lowell, MASTERS 1471 Elmwood Ave, Cranston, RI 02910-3849 Ph: (401) 724-8400 |
News Archive
W. L. Gore & Associates, Inc. today announced at the American Society for Metabolic and Bariatric Surgery Meeting that it has received approval from Health Canada for GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement. The device is specifically engineered to reduce the incidence of perioperative leaks and bleeding in a variety of open and minimally invasive surgeries.
A translational research team led by the National University of Singapore has harnessed CURATE.AI, a powerful artificial intelligence platform, to successfully treat a patient with advanced cancer, completely halting disease progression.
For the first time, immunization campaigns are being launched simultaneously tomorrow in 112 countries and territories in the World Health Organization Regions of the Americas, Eastern Mediterranean and Europe, with the goals of expanding immunization coverage and raising awareness of the importance of vaccines.
Medics training to become general practitioners reported a significant positive improvement in their mental wellbeing after participating in a specially-designed mindfulness program, a study from University of Warwick researchers shows.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Aztreonam for Injection, USP in two dosage strengths. Aztreonam is therapeutically equivalent to the reference-listed drug Azactam, which is marketed by Bristol-Myers Squibb.
› Verified 4 days ago
Arturo Ramirez, Counselor Medicare: Not Enrolled in Medicare Practice Location: 9 Carlo Ct, Cranston, RI 02921 Phone: 781-697-9225 | |
Kathy Young, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1471 Elmwood Ave, Cranston, RI 02910 Phone: 401-724-8400 Fax: 401-722-5280 | |
Jaimie Gutierrez, LMHC-A Counselor Medicare: Not Enrolled in Medicare Practice Location: 1052 Park Ave, Cranston, RI 02910 Phone: 401-461-5056 | |
Elisabeth Merrell, Counselor Medicare: Not Enrolled in Medicare Practice Location: 15 Fleming Rd, Cranston, RI 02920 Phone: 800-455-8839 Fax: 866-455-8839 | |
Jeremy May, MASTERS, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1471 Elmwood Ave, Cranston, RI 02910 Phone: 401-490-7320 Fax: 401-808-8685 | |
Dina Silva, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 156 Mulberry St, Cranston, RI 02910 Phone: 401-428-8065 | |
Kathryn Tarpey, BACHELORS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1471 Elmwood Ave, Cranston, RI 02910 Phone: 401-490-7320 Fax: 401-490-7694 |